The case for prioritizing malignant hematology services in low- and middle-income countries

IF 5 3区医学 Q1 HEMATOLOGY

Seminars in hematology Pub Date : 2023-09-01 DOI:10.1053/j.seminhematol.2023.08.005

Satish Gopal

引用次数: 1

Abstract

A clear case for can be made for prioritizing malignant hematology services in low- and middle-income countries based on large public health burden, convincing demonstrations of cure and control, innovation opportunities with likely worldwide implications, and sizable returns on investment for health systems and societies. We must now ensure that need and opportunity are matched by commensurate levels of investment and attention.

查看原文本刊更多论文

在低收入和中等收入国家优先提供恶性血液学服务的理由。

基于巨大的公共卫生负担、令人信服的治愈和控制示范、可能具有全球影响的创新机会以及卫生系统和社会的可观投资回报，可以明确提出在低收入和中等收入国家优先提供恶性血液病服务的理由。我们现在必须确保需求和机会与相应水平的投资和关注相匹配。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in hematology 医学-血液学

CiteScore

6.20

自引率

2.80%

发文量

审稿时长

35 days

期刊介绍： Seminars in Hematology aims to present subjects of current importance in clinical hematology, including related areas of oncology, hematopathology, and blood banking. The journal''s unique issue structure allows for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering a variety of articles that present dynamic and front-line material immediately influencing the field. Seminars in Hematology is devoted to making the important and current work accessible, comprehensible, and valuable to the practicing physician, young investigator, clinical practitioners, and internists/paediatricians with strong interests in blood diseases. Seminars in Hematology publishes original research, reviews, short communications and mini- reviews.